| 
      | 
  
      | 
  
      | 
 
| 
   The
  "active ingredients package" is common to all products in the
  SAIFER Range which require bacteria and virus control capability. The
  package is based around two new generation quaternary ammonium products whose
  spectrum of activity has been greatly extended beyond the level of efficacy
  normally associated with this group of compounds, by synergy and potentiating
  agents. By making use of this enhanced activity it has been possible to use
  very low concentrations of active ingredients in formulations where they
  would not normally be considered. As a consequence of this it has been
  possible to incorporate the package into products that are applied to skin
  and so achieve a performance in that area which has not been possible before,
  particularly with respect to virucidal activity. The specific advantages to the
  SAIFER Range can be seen by reviewing the appropriate product information
  sheet but the performance data tabulated below shows how extensive the
  efficacy of this particular "active package" is.  | 
 ||
| 
      | 
 |
| 
   | 
  
      | 
 
| 
      | 
 |
| 
   Staphylococcus
  aureus ATC 6538 (3 separate multi-resistant strains)  | 
 |
  
  | 
 |
| 
   Pseudomonas
  aeruginosa (multi-resistant strain)  | 
 |
  
  | 
 |
| 
   Spores
  of Bacillus subtilis  | 
 |
  
  | 
 |
  Clostridium difficile | 
 |
  
  | 
 |
| 
   Escherichia
  coli (including MRSA and other multi-resistant strains)  | 
 |
  
  | 
 |
  Mycobacterium tuberculosis | 
 |
  
  | 
 |
  Mycobacterium avium-intracellulare | 
 |
  
  | 
 |
  Klebsiella pneumoniae | 
 |
  
  | 
 |
  Salmonella choleraesuis | 
 |
  
  | 
 |
  Salmonella enteritidis | 
 |
  
  | 
 |
  Salmonella typhi | 
 |
  
  | 
 |
  Salmonella typhimurium | 
 |
  
  | 
 |
  Staphylococcus epidermidis | 
 |
  
  | 
 |
| 
   Streptococcus
  faecalis (multi-resistant strain)  | 
 |
  
  | 
 |
  Streptococcus pyogenes | 
 |
  
  | 
 |
  Acinetobacter calcoaceticus | 
 |
  
  | 
 |
  Bordatella bronchiseptica | 
 |
  
  | 
 |
  Enterobacter aerogenes & cloacae | 
 |
  
  | 
 |
  Fusobacterium necrophorum | 
 |
  
  | 
 |
  Listeria monocytogenes | 
 |
  
  | 
 |
  Pasteurella multocida | 
 |
  
  | 
 |
  Proteus mirabilis & vulgaris | 
 |
  
  | 
 |
  Serratia marcescens | 
 |
  
  | 
 |
  Shigella flexeri & sonnei | 
 |
  
  | 
 |
  Chlamydia psittaci | 
 |
  
  | 
 |
| 
      | 
 |
| 
   | 
  
      | 
 
| 
      | 
 |
  Adenovirus | 
 |
  
  | 
 |
| 
   Avian
  Bronchitis Virus  | 
 |
  
  | 
 |
| 
   Canine
  Distemper Virus  | 
 |
  
  | 
 |
| 
   Canine
  Parvovirus  | 
 |
  
  | 
 |
| 
   Feline
  Leukaemia Virus  | 
 |
  
  | 
 |
| 
   Feline
  Panleukopaenia Virus  | 
 |
  
  | 
 |
| 
   Feline
  Picornavirus  | 
 |
  
  | 
 |
| 
   Hepatitis
  B Virus   | 
 |
  
  | 
 |
| 
   Herpes
  Simplex Type 1 (HSV 1)  | 
 |
  
  | 
 |
| 
   Herpes
  Simplex Type 2  | 
 |
  
  | 
 |
| 
   Human
  Immunodeficiency Virus (HIV)  | 
 |
  
  | 
 |
| 
   Infectious
  Bovine Rhinotracheitis Virus  | 
 |
  
  | 
 |
  Influenza Virus Type A
   | 
 |
  
  | 
 |
| 
   Porcine
  Parvovirus  | 
 |
  
  | 
 |
| 
   Pseudorabies
  Virus  | 
 |
  
  | 
 |
| 
   Rabies
  Virus  | 
 |
  
  | 
 |
| 
   Respiratory
  Syncytial Virus  | 
 |
  
  | 
 |
| 
   Rubella
  Virus  | 
 |
  
  | 
 |
| 
   Transmissible
  Gastroenteritis  | 
 |
  
  | 
 |
| 
   Vaccinia
  Virus  | 
 |
  
  | 
 |
| 
      | 
 |
| 
   | 
  
      | 
 
| 
      | 
 |
| 
   Trichophyton
  mentagrophytes  | 
 |
  
  | 
 |
| 
   Candida
  albicans  | 
 |
  
  | 
 |
| 
   Aspergillus
  niger  | 
 |
  
  | 
 |